F 0644
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Coordinate assessments with the pre-admission screening and resident review program; and referring for
services as needed.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
medical record review and staff interview, the facility failed to ensure resident Preadmission Screening and
Resident Reviews (PASARRs) were accurate and included resident's mental health diagnoses and mental
health services. This affected two (#05 and #14) of the three residents reviewed for PASARRs. The facility
census was 71 residents.
Findings include:
1) Review of the medical record for Resident #05 revealed an admission date of 02/21/23 with diagnoses
including dementia, psychosis, mood disorder. Review of the current diagnoses revealed a new diagnosis
of anxiety added on 07/26/24.
Review of the quarterly Minimum Data Set (MDS) assessment dated [DATE], revealed Resident #05 had
severely impaired cognition.
Review of the completed PASARR documents revealed the facility did not complete a new PASARR
designation following the addition of the anxiety diagnosis on 07/26/24.
2) Review of the medical record for Resident #14 revealed an admission date of 10/03/23 with diagnoses
including acute and chronic respiratory failure, chronic obstructive pulmonary disease, diabetes mellitus
type II, congestive heart failure, acute kidney failure, hypertension, hypothyroidism, depression,
diverticulosis, anemia, cerebrovascular disease, neuromuscular dysfunction of the bladder, insomnia,
anxiety, unspecified psychosis, bipolar disorder, and adult failure to thrive. Review of the current diagnoses
revealed a new diagnosis of unspecified psychosis not due to a substance or known physiological condition
was added on 03/21/25.
Review of the quarterly Minimum Data Set (MDS) assessment dated [DATE] revealed Resident #14 had
severely impaired cognition.
Review of the completed PASARR documents revealed the facility did not complete a new PASSAR
designation following the addition of the unspecified psychosis diagnosis on 03/21/25.
Interview with Social Services Director (SSD) #14 on 05/08/25 at 09:47 A.M., verified a new PASARR
should have been completed for Resident #05 following a new diagnosis of anxiety on 07/26/24. SSD #14
also verified a new PASARR should have been completed for Resident #14 following a new diagnosis of
unspecified psychosis on 03/21/25.
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 5
Event ID:
365621
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365621
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/08/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Hillsboro Post Acute
1141 Northview Drive
Hillsboro, OH 45133
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0759
Ensure medication error rates are not 5 percent or greater.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
medical record reviews, observations, and staff interviews, the facility failed to ensure the medication error
rate was less than five percent, as evidenced by three medication errors out of 31 opportunities observed,
resulting in 9.68 percent (%) medication error rate. This affected two (#17 and #60) of the four residents
observed for medication administration. The facility census was 71.
Residents Affected - Few
Findings include:
1) Record review for Resident #17 revealed the resident was admitted to the facility on [DATE] and had
diagnoses which included hypertension, bipolar disorder, and insomnia.
Review of the physician order for Resident #17 dated 03/07/25, revealed an order for Amlodipine Besylate
10 milligrams (mg) to be administered one time a day for hypertension and to hold the medication for a
systolic blood pressure (SBP) below 120 millimeters of mercury (mm/Hg) or a diastolic blood pressure
(DBP) below 80 mm/Hg.
Review of the physician order for Resident #17 dated 03/10/25, revealed an order for Hydralazine 25 mg to
be administered twice a day for hypertension and administer the medication if the resident's SBP is over
160 mm/Hg and/or DBP over 120 mm/Hg.
Observation of the medication administration on 05/06/25 at 8:28 A.M., with Licensed Practical Nurse
(LPN) #517 revealed medications including Amlodipine Besylate 10 mg and Hydralazine 25 mg were
prepared for administration to Resident #17. LPN #517 entered the room of Resident #17 with the prepared
medications and obtained the residents Blood Pressure (BP) with results of SBP 155 mg/Hg and DBP 74
mm/Hg. LPN #517 administered all ordered medications, including the Amlodipine Besylate and
Hydralazine, to the resident and exited the room. Interview with LPN #517 at the same time, verified the
medications were administered to Resident #17.
Interview on 05/07/25 at 10:05 A.M., with the Director of Nursing (DON) verified Resident #17 should not
have been administered Amlodipine Besylate or Hydralazine by LPN #517 on 05/06/25 at 8:20 A.M. due to
the residents BP reading being outside the parameters for administration.
2) Record review for Resident #60 revealed the resident was admitted to the facility on [DATE] and had
diagnoses which included paroxysmal atrial fibrillation, hypertension, and presence of a cardiac
pacemaker.
Review of the physician order dated 03/06/25 revealed an order for Digoxin 125 micrograms (mcg) to be
administered once a day for the Heart.
Observation of the medication administration on 05/06/25 at 8:20 A.M., with LPN #517 revealed
medications including Digoxin 125 mcg were prepared for administration to Resident #60. LPN #517
entered the room of Resident #60 with the prepared medications and obtained the residents pulse using a
pulse oximeter placed on the residents left first finger. The pulse oximeter was in place for less than 30
seconds with a result of 77 heart beats per minute. LPN #517 administered all ordered medications,
including the Digoxin, to the resident and exited the room. Interview with LPN #517 at the same time,
verified the medication was administered to Resident #17.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
365621
If continuation sheet
Page 2 of 5
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365621
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/08/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Hillsboro Post Acute
1141 Northview Drive
Hillsboro, OH 45133
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0759
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Interview on 05/07/25 at 10:05 A.M., with the DON verified the facility nurses should obtain a resident's
apical pulse (the pulse rate located at the apex of the heart on the left side of the chest) for one full minute
prior to the administration of Digoxin.
Review of the facility policy titled Administering Medications, revised 04/2019, revealed medications are
administered in a safe and timely manner, and as prescribed.
Event ID:
Facility ID:
365621
If continuation sheet
Page 3 of 5
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365621
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/08/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Hillsboro Post Acute
1141 Northview Drive
Hillsboro, OH 45133
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0760
Ensure that residents are free from significant medication errors.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
medical record reviews, observations, staff interview, and review of facility policy, the facility failed to ensure
medications were administered per physician's order resulting in significant medication errors. This affected
two (#17 and #60) of the four residents observed for medication administration. The facility census was 71.
Residents Affected - Few
Findings include:
1) Record review for Resident #17 revealed the resident was admitted to the facility on [DATE] and had
diagnoses which included hypertension, bipolar disorder, and insomnia.
Review of the physician order for Resident #17 dated 03/07/25, revealed an order for Amlodipine Besylate
10 milligrams (mg) to be administered one time a day for hypertension and to hold the medication for a
systolic blood pressure (SBP) below 120 millimeters of mercury (mm/Hg) or a diastolic blood pressure
(DBP) below 80 mm/Hg.
Review of the physician order for Resident #17 dated 03/10/25, revealed an order for Hydralazine 25 mg to
be administered twice a day for hypertension and administer the medication if the resident's SBP is over
160 mm/Hg and/or DBP over 120 mm/Hg.
Observation of the medication administration on 05/06/25 at 8:28 A.M., with Licensed Practical Nurse
(LPN) #517 revealed medications including Amlodipine Besylate 10 mg and Hydralazine 25 mg were
prepared for administration to Resident #17. LPN #517 entered the room of Resident #17 with the prepared
medications and obtained the residents Blood Pressure (BP) with results of SBP 155 mg/Hg and DBP 74
mm/Hg. LPN #517 administered all ordered medications, including the Amlodipine Besylate and
Hydralazine, to the resident and exited the room. Interview with LPN #517 at the same time, verified the
medications were administered to Resident #17.
Interview on 05/07/25 at 10:05 A.M., with the Director of Nursing (DON) verified Resident #17 should not
have been administered Amlodipine Besylate or Hydralazine by LPN #517 on 05/06/25 at 8:20 A.M. due to
the residents BP reading being outside the parameters for administration.
2) Record review for Resident #60 revealed the resident was admitted to the facility on [DATE] and had
diagnoses which included paroxysmal atrial fibrillation, hypertension, and presence of a cardiac
pacemaker.
Review of the physician order for Resident #60 dated 03/06/25 revealed an order for Digoxin 125
micrograms (mcg) to be administered once a day for the Heart.
Observation of the medication administration on 05/06/25 at 8:20 A.M., with LPN #517 revealed
medications including Digoxin 125 mcg were prepared for administration to Resident #60. LPN #517
entered the room of Resident #60 with the prepared medications and obtained the residents pulse using a
pulse oximeter placed on the residents left first finger. The pulse oximeter was in place for less than 30
seconds with a result of 77 heart beats per minute. LPN #517 administered all ordered medications,
including the Digoxin, to the resident and exited the room. Interview with LPN #517 at the same time,
verified the medication was administered to Resident #17.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
365621
If continuation sheet
Page 4 of 5
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365621
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
05/08/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Hillsboro Post Acute
1141 Northview Drive
Hillsboro, OH 45133
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0760
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Interview on 05/07/25 at 10:05 A.M., with the DON verified the facility nurses should obtain a resident's
apical pulse (the pulse rate located at the apex of the heart on the left side of the chest) for one full minute
prior to the administration of Digoxin.
Review of the facility policy titled Administering Medications, revised 04/2019, revealed medications are
administered in a safe and timely manner, and as prescribed.
Event ID:
Facility ID:
365621
If continuation sheet
Page 5 of 5